FDA debates trial-data secrecy
Wednesday, July 30, 2014 - 09:01
in Health & Medicine
US drug regulator weighs up merits of disclosing preliminary results.Nature 511 519 doi: 10.1038/511519a
US drug regulator weighs up merits of disclosing preliminary results.Nature 511 519 doi: 10.1038/511519a